Garmin partners with King’s College London for maternal health research

NEW YORK - Garmin (NYSE:GRMN), the $45.6 billion market cap technology company with impressive gross profit margins of 59%, announced Wednesday a collaboration with King’s College London, becoming the exclusive smartwatch provider for the Enhanced Maternal and Baby Results with AI-supported Care and Empowerment (EMBRACE) research program. According to InvestingPro data, Garmin maintains excellent financial health with strong profitability metrics and has shown nearly 20% revenue growth over the last twelve months.

The partnership, revealed during the Garmin Health Summit at the New York Stock Exchange, will collect biometric data from up to 40,000 adult participants worldwide, including pregnant women and their partners, according to a company press release. Trading near its 52-week high, Garmin’s stock performance reflects investor confidence in its healthcare technology initiatives. InvestingPro analysis indicates the stock is currently trading above its Fair Value, with 14 additional ProTips available to subscribers.

Participants will receive Garmin smartwatches or fitness trackers to record physiological metrics including heart rate, sleep patterns, and physical activity. The data will support AI-based clinical studies addressing conditions such as gestational diabetes, pregnancy hypertension, and perinatal depression.

"King’s is committed to utilizing new and evolving technologies — like AI and wearables — to not only further academic research, but also provide critical insights needed to address policy and healthcare challenges around the world," said Josip Car, King’s College London Professor of Population and Digital Health Sciences.

The EMBRACE program is funded by philanthropic research organization Inkfish, which previously made what was described as the largest single donation in the university’s history.

Jörn Watzke, Senior Director of Garmin Health, called the collaboration "an important milestone for Garmin, underscoring our rigorous standards for data quality, integration and privacy."

The research aims to develop AI-based prediction algorithms that could identify digital biomarkers to support personalized interventions and improve health outcomes for mothers, partners, and babies.

King’s College London ranks among the top 35 universities globally and 11th for Life Sciences and Medicine, according to QS World University Rankings 2026. For detailed insights into Garmin’s financial health, growth prospects, and comprehensive analysis, investors can access the full Pro Research Report, available exclusively on InvestingPro, which covers this and 1,400+ other top US stocks with expert analysis and actionable intelligence.

In other recent news, Garmin reported its second-quarter 2025 earnings, showcasing a strong financial performance with earnings per share (EPS) of $2.17, beating the forecasted $1.86 by 16.67%. The company also exceeded revenue expectations, reporting $1.815 billion compared to the anticipated $1.7 billion. In addition to its financial results, Garmin introduced several new products that highlight its focus on innovation in the tech space. The company unveiled the Rally 110 and 210 cycling power meters, featuring rechargeable batteries and improved accuracy for cyclists. Furthermore, Garmin launched the Edge 550 and 850 cycling computers, designed with advanced training features and enhanced displays. Another significant product release is the fēnix 8 Pro series smartwatches, which are the first to include built-in satellite and cellular connectivity. Garmin also introduced the GPSMAP H1i Plus, a premium GPS handheld navigator with enhanced satellite communication capabilities. These developments reflect Garmin’s ongoing commitment to expanding its product offerings and meeting diverse consumer needs.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.